Pembrolizumab injection trials for Lung cancer

All Pembrolizumab injection trials · All Lung cancer trials

Phase breakdown

Recruiting trials studying Pembrolizumab injection for Lung cancer

• Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
  NCT05899608 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 260 locations
• Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
  NCT06767514 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 274 locations
• Development and Analysis of a Stool Bank for Cancer Patients
  NCT04291755 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Pembrolizumab Plus Bevacizumab and Chemotherapy for ALK-rearranged NSCLC With Persistent 5'ALK
  NCT05266846 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials study Pembrolizumab injection for Lung cancer?

4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.